当前位置：
X-MOL 学术
›
J. Microbiol. Immunol. Infect.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
Journal of Microbiology, Immunology and Infection ( IF 7.4 ) Pub Date : 2020-04-03 , DOI: 10.1016/j.jmii.2020.03.032 Chien-Yu Cheng,Yu-Lin Lee,Cheng-Pin Chen,Yi-Chun Lin,Chun-Eng Liu,Chia-Hung Liao,Shu-Hsing Cheng
更新日期：2020-04-03
Journal of Microbiology, Immunology and Infection ( IF 7.4 ) Pub Date : 2020-04-03 , DOI: 10.1016/j.jmii.2020.03.032 Chien-Yu Cheng,Yu-Lin Lee,Cheng-Pin Chen,Yi-Chun Lin,Chun-Eng Liu,Chia-Hung Liao,Shu-Hsing Cheng
An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.
京公网安备 11010802027423号